Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms

por Van Kerrebroeck, Philip E. V.
Publicado 2010

Pharmacotherapy for Nocturia

por Andersson, Karl-Erik, Van Kerrebroeck, Philip
Publicado 2018

New insights into perinatal testicular torsion

por Callewaert, Piet R. H., Van Kerrebroeck, Philip
Publicado 2009

Sacral neuromodulation as a treatment for neuropathic clitoral pain after abdominal hysterectomy

por Marcelissen, Tom, Van Kerrebroeck, Philip, de Wachter, Stefan
Publicado 2010

The value of urodynamic tools to guide patient selection in sacral neuromodulation

por Drossaerts, Jamie, Rademakers, Kevin, van Koeveringe, Gommert, Van Kerrebroeck, Philip
Publicado 2015

A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies

por van Renterghem, Koenraad, Van Koeveringe, Gommert, Achten, Ruth, van Kerrebroeck, Philip
Publicado 2009

Overactive Bladder Syndrome and the Potential Role of Prostaglandins and Phosphodiesterases: An Introduction

por Rahnama'i, Mohammad Sajjad, Van Koeveringe, Gommert A., Van Kerrebroeck, Philip E.
Publicado 2013

Rationale for the Use of Prostaglandins and Phosphodiesterase Inhibitors in the Treatment of Functional Bladder Disorders

por Rahnama'i, Mohammad Sajjad, Van Koeveringe, Gommert A., Van Kerrebroeck, Philip E.
Publicado 2013

Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive...

por Van Kerrebroeck, Philip EV, Kelleher, Con J, Coyne, Karin S, Kopp, Zoe, Brodsky, Marina, Wang, Joseph T
Publicado 2009

The effect of indomethacin on the muscarinic induced contractions in the isolated normal guinea pig urinary bladder

por Rahnama’i, Mohammad S, van Koeveringe, Gommert A, van Kerrebroeck, Philip EV, de Wachter, Stefan GG
Publicado 2013

Protocol for a prospective neuroimaging study investigating the supraspinal control of lower urinary tract function in healthy controls and patients with non-neurogenic lower urina...

por Walter, Matthias, Michels, Lars, Kollias, Spyros, van Kerrebroeck, Philip E, Kessler, Thomas M, Mehnert, Ulrich
Publicado 2014

Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A...

por Drake, Marcus J., Oelke, Matthias, Snijder, Robert, Klaver, Monique, Traudtner, Klaudia, van Charldorp, Karin, Bongaerts, Dominique, Van Kerrebroeck, Philip
Publicado 2017

Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system

por Blok, Bertil, Van Kerrebroeck, Philip, de Wachter, Stephan, Ruffion, Alain, Van der Aa, Frank, Perrouin‐Verbe, Marie Aimée, Elneil, Sohier
Publicado 2020

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

por Chapple, Christopher R., Nitti, Victor W., Khullar, Vik, Wyndaele, Jean Jacques, Herschorn, Sender, van Kerrebroeck, Philip, Blauwet, Mary Beth, Siddiqui, Emad
Publicado 2014

A practical approach to the management of nocturia

por Oelke, Matthias, De Wachter, Stefan, Drake, Marcus J., Giannantoni, Antonella, Kirby, Mike, Orme, Susan, Rees, Jonathan, van Kerrebroeck, Philip, Everaert, Karel
Publicado 2017

Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms

por te Dorsthorst, Manon, Digesu, Alex, van Kerrebroeck, Philip, Elneil, Sohier, van Breda, Jetske, Janssen, Dick, Martens, Frank, van Balken, Michael, Heesakkers, John
Publicado 2022

New Technologies and Applications in Sacral Neuromodulation: An Update

por De Wachter, Stefan, Knowles, Charles H., Elterman, Dean S., Kennelly, Michael J., Lehur, Paul A., Matzel, Klaus E., Engelberg, Stefan, Van Kerrebroeck, Philip E. V.
Publicado 2019

Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients

por Reekmans, Mathias, Janssen, Janine M. W., Vrijens, Desiree M. J., Smits, Martijn A. C., van Koeveringe, Gommert A., Van Kerrebroeck, Philip E. V. A.
Publicado 2021

A phase II dose-ranging study of mirabegron in patients with overactive bladder

por Chapple, Christopher R., Dvorak, Vladimir, Radziszewski, Pjotr, Van Kerrebroeck, Philip, Wyndaele, Jean Jacques, Bosman, Brigitte, Boerrigter, Peter, Drogendijk, Ted, Ridder, Arwin, Van Der Putten-Slob, Ingrid, Yamaguchi, Osamu
Publicado 2013

Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice

por Dudding, Thomas C., Lehur, Paul A., Sørensen, Michael, Engelberg, Stefan, Bertapelle, Maria Paola, Chartier‐Kastler, Emmanuel, Everaert, Karel, Van Kerrebroeck, Philip, Knowles, Charles H., Lundby, Lilli, Matzel, Klaus E., Muñoz‐Duyos, Arantxa, Rydningen, Mona B., de Wachter, Stefan
Publicado 2021